SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Senetek (SNTK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ray who wrote (3)9/2/2002 6:44:22 PM
From: SemiBull   of 101
 
"...In a move that befuddles many pundits, Thieme has bet heavily on the penny stock of Senetek Plc (NasdaqSC:SNTK - News), a British company that makes an injectable drug to fight impotence. Most mutual funds embrace diversification. Thieme does not. More than 80 percent of his American Heritage fund is now invested in that obscure stock, which actually has risen 8.3 percent this year to trade at 65 cents on Friday.

Thieme likes the prospects of Senetek's drug, despite the dominance of Pfizer's Viagra. He says Senetek has grown to such a large position in the fund not because he has gobbled up huge helpings of the stock but because he has held on to it while selling other shares. Thieme has unloaded other stocks to raise cash to pay off investors who bailed out of the fund...."
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News